Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11474661 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
Condition: Leukemia
Intervention: Biological: BL22 immunotoxin

Indicates status has not been verified in more than two years